CN1823972A - Medicine for treating celevical vertebra disease - Google Patents
Medicine for treating celevical vertebra disease Download PDFInfo
- Publication number
- CN1823972A CN1823972A CN 200510119090 CN200510119090A CN1823972A CN 1823972 A CN1823972 A CN 1823972A CN 200510119090 CN200510119090 CN 200510119090 CN 200510119090 A CN200510119090 A CN 200510119090A CN 1823972 A CN1823972 A CN 1823972A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- treating
- cervical spondylosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of tablet, capsule, particle, powder, pill, or oral liquid for treating servical spondylopathy and servical hyperosteogeny is prepared from 6 Chinese-medicinal materials including white peony root, spatholobus stem, pueraria root, liquorice root, etc.
Description
Technical field
The present invention relates to a kind of Chinese medicine, promptly a kind of medicine for the treatment of cervical spondylosis.
Background technology
In prior art, the Chinese invention patent ublic specification of application disclosed a kind of name and has been called " a kind of medicine for the treatment of neck-shoulder pain, lumbago and leg pain disease " application for a patent for invention on October 29th, 2003, number of patent application: 03129770.6, the applying date: 2003.05.16, it comprises Radix Cyathulae, Radix Puerariae, Radix Gentianae Macrophyllae, Radix Clematidis, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Corydalis, Radix Aconiti, Radix Angelicae Pubescentis, Scolopendra, Rhizoma Gastrodiae, Scorpio, Ramulus Cinnamomi, Fructus Chaenomelis Herba Siegesbeckiae, Caulis Sinomenii, Caulis Piperis Kadsurae, Herba Ephedrae, Squama Manis, Caulis Spatholobi, Radix Stephaniae Tetrandrae, Cortex erythrinae, Agkistrodon, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Herba Asari, Radix Glycyrrhizae, Poria, Rhizoma Curcumae Longae, 30 multi-flavor compositions such as Semen Strychni (processed), its shortcoming is the prescription complexity, the cost height, cannot not cure mainly outstandingly, uncertain therapeutic efficacy is cut.
Summary of the invention
The objective of the invention is provides a kind of prescription simple at above-mentioned deficiency, and curative effect is treated the medicine of cervical spondylosis more significantly.
Technical solution of the present invention is: it is made the medicine of treatment cervical spondylosis by the raw material of following parts by weight: Radix Paeoniae Alba 30-40 part, Fructus Chaenomelis 10-12 part, Caulis Spatholobi 10-15 part, Radix Clematidis 10-15 part, Radix Puerariae 10-12 part and Radix Glycyrrhizae 10-12 part.Can be mixed and made into tablet, capsule, granule, powder, pill, oral liquid or other conventional formulation by pharmaceutical carrier, additive or adjuvant commonly used in above-mentioned each medicinal raw material and the pharmacy.
Be preferably 11 parts in 35 parts of the Radix Paeoniae Albas, 11 parts of Fructus Chaenomeliss, 13 parts of Caulis Spatholobis, 13 parts of Radix Clematidis, 11 parts of Radix Puerariaes and Radix Glycyrrhizae.
Motherland's medical science is thought liver governing tendons, kidney governing bones.Cervical spondylosis is that deficiency of both the liver and kidney, wind-cold damp pathogen go deep into muscles and bones being reluctant to leave and do not go, the invasion and attack meridians, go deep into muscles and bones with the passing of time, the muscle arteries and veins arrests tightly, forms the card of rheumatism involving the bone.Its method of treatment should be enriched blood, collateral dredging, dispelling cold by warming the meridian removing dampness, i.e. nourishing the liver and kidney, mediation muscle arteries and veins.Reuse the Radix Paeoniae Alba in the side and be monarch, the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain, suppressing liver-YANG; Minister is with Fructus Chaenomelis, relaxing muscles and tendons and activating QI and blood in the collateral, removing dampness stopping numbness pain; Caulis Spatholobi, Radix Clematidis are invigorated blood circulation, are enriched blood, relaxing muscles and tendons and activating QI and blood in the collateral, wind-expelling pain-stopping; Assistant is with the Radix Puerariae relieving muscles diaphoresis; Radix Glycyrrhizae is concocted all medicines for making, and all medicines cooperate, and plays nourishing the liver and kidney, mediation muscle feeling pulse effect altogether.
Preparation technology is the conventional existing technology of tradition, as being example with the granule, carries out that pre-treatment → water is carried → concentrated, drying → mixing → system granule → drying → check → packing gets final product.
Function with cure mainly: nourishing the liver and kidney, mediation muscle arteries and veins.Be used for the treatment of diseases such as hyperosteogeny, neck pain, activity that cervical spondylosis is caused are unfavorable, aching pain in should and back, disease of hand, headache.
Usage and consumption: with the granule is example, oral, every day three times, each 10 grams.Can cure in general 2-20 days.
Report is looked in the clinical sight of the medicine of treatment cervical spondylosis: by the observation of curative effect that 40 routine hyperosteogeny of cervical vertebra patients are taken, and do not find to have bad reflection, wherein an example is suffered from more than 20 year multi-treatment of cervical spondylosis and was taken this medicine 2 days after invalid, and symptom obviously alleviates, and takes recovery from illness in 10 days.Through long-term observation, do not have recurrence.Wherein male 22 examples of 40 routine patients, women 18 examples.30-40 year 8 examples, 40-50 year 14 examples, 18 examples more than 50.Course of disease 1-3 5 examples, 4-6 12 examples, 23 examples more than 7 years.Took medicine minimum 2 days, can cure in general 20 days.Efficacy assessment standard: complete: clinical symptoms is eliminated, and functional rehabilitation is normal.Produce effects: clinical symptoms is eliminated substantially, and functional rehabilitation is normal.Effectively: clinical symptom relief, funtion part is recovered.Invalid: symptom, function are not recovered.Among the 40 routine patients, 36 examples that wherein heal entirely account for 90%; Produce effects 4 examples account for 10%; Aggregate efficiency 100%.
Advantage of the present invention is: the clinical practice by for many years proves, with existing to compare prescription with veriety simple, with low cost, cures mainly outstandingly, cures highly, evident in efficacy, has no side effect, to the hyperosteogeny of cervical vertebra determined curative effect.
Below in conjunction with embodiment the present invention is described in further detail.
The specific embodiment
Embodiment 1
The medicine of treatment cervical spondylosis is made by the raw material of following parts by weight: 11 parts in 30 parts of the Radix Paeoniae Albas, 10 parts of Fructus Chaenomeliss, 10 parts of Caulis Spatholobis, 10 parts of Radix Clematidis, 10 parts of Radix Puerariaes and Radix Glycyrrhizae.
Embodiment 2
The medicine of treatment cervical spondylosis is made by the raw material of following parts by weight: 11 parts in 35 parts of the Radix Paeoniae Albas, 11 parts of Fructus Chaenomeliss, 13 parts of Caulis Spatholobis, 13 parts of Radix Clematidis, 11 parts of Radix Puerariaes and Radix Glycyrrhizae.
Embodiment 3
The medicine of treatment cervical spondylosis is made by the raw material of following parts by weight: 12 parts in 40 parts of the Radix Paeoniae Albas, 12 parts of Fructus Chaenomeliss, 15 parts of Caulis Spatholobis, 15 parts of Radix Clematidis, 12 parts of Radix Puerariaes and Radix Glycyrrhizae.
Claims (2)
1, a kind of medicine for the treatment of cervical spondylosis is characterized in that it is made by the raw material of following parts by weight: Radix Paeoniae Alba 30-40 part, Fructus Chaenomelis 10-12 part, Caulis Spatholobi 10-15 part, Radix Clematidis 10-15 part, Radix Puerariae 10-12 part and Radix Glycyrrhizae 10-12 part.
2,, it is characterized in that 11 parts in 35 parts of the Radix Paeoniae Albas, 11 parts of Fructus Chaenomeliss, 13 parts of Caulis Spatholobis, 13 parts of Radix Clematidis, 11 parts of Radix Puerariaes and Radix Glycyrrhizae according to the medicine of the described treatment cervical spondylosis of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101190907A CN100336527C (en) | 2005-12-14 | 2005-12-14 | Medicine for treating celevical vertebra disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101190907A CN100336527C (en) | 2005-12-14 | 2005-12-14 | Medicine for treating celevical vertebra disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1823972A true CN1823972A (en) | 2006-08-30 |
| CN100336527C CN100336527C (en) | 2007-09-12 |
Family
ID=36934912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101190907A Expired - Fee Related CN100336527C (en) | 2005-12-14 | 2005-12-14 | Medicine for treating celevical vertebra disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100336527C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083629A (en) * | 2011-11-01 | 2013-05-08 | 焦国荣 | Medicine composition for treating cervical vertebra hyperostosis and preparation method thereof |
| CN103977101A (en) * | 2014-05-10 | 2014-08-13 | 陈筠 | Traditional Chinese medicine composition for treating spur |
| CN104208296A (en) * | 2014-07-31 | 2014-12-17 | 陈钏黄 | Medicine composition for treating cervical spondylosis, preparation method and application thereof |
| CN104739998A (en) * | 2015-04-15 | 2015-07-01 | 曾盛钊 | Herbal tea bag for treating cervical spondylosis |
| CN104758415A (en) * | 2015-04-15 | 2015-07-08 | 曾盛钊 | Medicinal liquor used for treating cervical vertebra inflammation |
| CN105497786A (en) * | 2015-12-22 | 2016-04-20 | 王琪 | Traditional Chinese medicine composition for treating bone hyperplasia |
| CN107007691A (en) * | 2017-05-26 | 2017-08-04 | 王滋东 | It is a kind of to treat medicine of cervical spondylopathy and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1197613C (en) * | 2003-05-16 | 2005-04-20 | 南风龙 | Medicine for treating neck, shoulder, waist and leg pains |
| CN1296077C (en) * | 2004-05-09 | 2007-01-24 | 张国春 | Chinese medicinal capsule for treating ostealgia disease |
-
2005
- 2005-12-14 CN CNB2005101190907A patent/CN100336527C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083629A (en) * | 2011-11-01 | 2013-05-08 | 焦国荣 | Medicine composition for treating cervical vertebra hyperostosis and preparation method thereof |
| CN103083629B (en) * | 2011-11-01 | 2014-01-01 | 焦国荣 | Medicine composition for treating cervical vertebra hyperostosis and preparation method thereof |
| CN103977101A (en) * | 2014-05-10 | 2014-08-13 | 陈筠 | Traditional Chinese medicine composition for treating spur |
| CN104208296A (en) * | 2014-07-31 | 2014-12-17 | 陈钏黄 | Medicine composition for treating cervical spondylosis, preparation method and application thereof |
| CN104739998A (en) * | 2015-04-15 | 2015-07-01 | 曾盛钊 | Herbal tea bag for treating cervical spondylosis |
| CN104758415A (en) * | 2015-04-15 | 2015-07-08 | 曾盛钊 | Medicinal liquor used for treating cervical vertebra inflammation |
| CN105497786A (en) * | 2015-12-22 | 2016-04-20 | 王琪 | Traditional Chinese medicine composition for treating bone hyperplasia |
| CN107007691A (en) * | 2017-05-26 | 2017-08-04 | 王滋东 | It is a kind of to treat medicine of cervical spondylopathy and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100336527C (en) | 2007-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100336527C (en) | Medicine for treating celevical vertebra disease | |
| CN101361872A (en) | Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing | |
| CN103330805B (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN102895460A (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN109700856A (en) | A kind of Chinese medicine external prescription relieved pain with promoting blood circulation and removing obstruction in channels, relaxing muscles and tendons | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN1468628A (en) | Medicine for treatnig ovarian cyst | |
| CN101485780A (en) | Medicinal liquor for treating hyperosteogeny disease and preparation method thereof | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN103417788B (en) | One treats fracture Chinese medicine for oral administration | |
| CN103157006B (en) | Oral traditional Chinese medicine formula for treating osteoarthritis | |
| CN102949507B (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN104758652A (en) | Traditional Chinese medicine composition for treating dizziness | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN1943635A (en) | Chinese traditional medicinal preparation for treating bone injuries and osteonosus | |
| CN103386050B (en) | Chinese patent drug pill used for treating rheumatic ostealgia, cervical spondylosis and lumbar spondylosis | |
| CN1048169C (en) | Zibushenyang Yuanqiguifu Dai (a medicated band for nourishing kidney-yang and restoring primordial qi) | |
| CN1557365A (en) | Medicine | |
| CN1232296C (en) | Chinese herbal medicine preparation for treating bone and muscle injuries | |
| CN104587394A (en) | Traditional Chinese medicine composition for treating delayed union and nonunion | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN103861039A (en) | Bone-setting medicament and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070912 Termination date: 20131214 |